Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 132 results:
[ Συντάκτης] Τίτλος Τύπος Έτος Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Editorial: adiponectin in health and disease: current evidence and therapeutic perspectives..
Curr Med Chem. 19(32), 5425-6.
(2012). Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease..
Ann Hepatol. 15(5), 705-14.
(2016). Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?.
Metabolism. 96, iii-v.
(2019). Metabolism, Clinical and Experimental: seventy years young and growing..
Metabolism. 155333.
(2022). Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease..
Hormones (Athens). 12(3), 405-16.
(2013). The intriguing connections of leptin to hyperparathyroidism..
Endocrine. 57(3), 376-387.
(2017). Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules..
J Cancer Res Clin Oncol. 134(9), 953-60.
(2008). Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis..
Hepatol Res. 40(4), 446-7.
(2010). Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management..
Metabolism. 155936.
(2024). Leptin in nonalcoholic fatty liver disease: a narrative review..
Metabolism. 64(1), 60-78.
(2015). Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1..
J Clin Densitom. 13(2), 190-6.
(2010). Asporin levels are low in patients with nonalcoholic fatty liver disease and increase after vitamin E treatment..
Hormones (Athens).
(2019). Nonalcoholic fatty liver disease in males with low testosterone concentrations..
Diabetes Metab Syndr. 14(5), 1571-1577.
(2020). The association between Helicobacter pylori infection and insulin resistance: a systematic review..
Helicobacter. 16(2), 79-88.
(2011). Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis..
Diabetologia. 59(1), 30-43.
(2016). Nonalcoholic fatty liver disease and polycystic ovary syndrome..
Ann Hepatol. 14(6), 941-3.
(2015). Adult hypophosphatasia treated with reduced frequency of teriparatide dosing..
J Musculoskelet Neuronal Interact. 21(4), 584-589.
(2021). Comment on: Jeon et al. Helicobacter pylori Infection Is Associated With an Increased Rate of Diabetes. Diabetes Care 2012;35:520-525..
Diabetes Care. 35(7), e53; author reply e54.
(2012). Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists..
Metabolism. 66, 64-68.
(2017). Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease..
Exp Clin Endocrinol Diabetes.
(2019). Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implications..
Hepatobiliary Pancreat Dis Int.
(2023). Irisin in patients with nonalcoholic fatty liver disease..
Metabolism. 63(2), 207-17.
(2014). Juvenile Paget disease..
Metabolism. 80, 15-26.
(2018). Clinical complications following thyroid fine-needle biopsy: a systematic review..
Clin Endocrinol (Oxf). 71(2), 157-65.
(2009). Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns..
Metabolism. 104, 154144.
(2020).